CA2059692C
(en)
*
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
US5681570A
(en)
*
|
1995-01-12 |
1997-10-28 |
Connaught Laboratories Limited |
Immunogenic conjugate molecules
|
AU725279B2
(en)
*
|
1995-06-07 |
2000-10-12 |
Alberta Research Council Inc. |
Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them
|
TW409058B
(en)
*
|
1996-06-06 |
2000-10-21 |
Daiichi Seiyaku Co |
Method for preparation of a drug complex
|
DE69708318T3
(de)
*
|
1996-08-27 |
2006-11-16 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
|
GB9700939D0
(en)
*
|
1997-01-17 |
1997-03-05 |
Microbial Technics Limited |
Therapy
|
WO1998042718A1
(en)
*
|
1997-03-26 |
1998-10-01 |
The Brigham And Women's Hospital, Inc. |
Method for generating saccharide fragments
|
US6224880B1
(en)
|
1997-09-24 |
2001-05-01 |
Merck & Co., Inc. |
Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines
|
AU759391B2
(en)
*
|
1998-02-12 |
2003-04-10 |
Wyeth Holdings Corporation |
Pneumococcal and meningococcal vaccines formulated with interleukin-12
|
US7018637B2
(en)
*
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
US20080096236A1
(en)
*
|
1998-08-25 |
2008-04-24 |
Binax, Inc. |
Method for Detecting the Presence of Target Bacteria or a Target Component Carbohydrate Antigen Thereof
|
US6824997B1
(en)
*
|
1998-09-18 |
2004-11-30 |
Binax, Inc. |
Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
|
US9134303B1
(en)
|
1998-08-25 |
2015-09-15 |
Alere Scarborough, Inc. |
ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
GB0115176D0
(en)
*
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
EP1494687A2
(de)
*
|
2002-03-08 |
2005-01-12 |
Eli Lilly And Company |
Immunomodulierende polymerische antigenen zur behamdlung von entzündlichen erkrankungen
|
GB0313916D0
(en)
|
2003-06-16 |
2003-07-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
JP2008513406A
(ja)
|
2004-09-22 |
2008-05-01 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物
|
GB0502096D0
(en)
*
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
EP2425853A1
(de)
|
2005-04-08 |
2012-03-07 |
Wyeth LLC |
Multivalente Pneumokokken-Polysaccharidproteinkonjugatzusammensetzung
|
EP1896062B1
(de)
|
2005-06-27 |
2010-03-31 |
GlaxoSmithKline Biologicals S.A. |
Immunogene zusammensetzung
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
NO346529B1
(no)
|
2005-12-22 |
2022-09-26 |
Glaxosmithkline Biologicals Sa |
Bruk av et immunogenpreparat for småbarn, omfattende 22F sakkaridkonjugat
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
BRPI0710210A2
(pt)
|
2006-03-30 |
2011-05-24 |
Glaxomithkline Biolog S A |
composição imunogênica, vacina, métodos para preparar a vacina, e para prevenir ou tratar infecção estafilocócica, uso da composição imunogênica, e, processo para conjugar oligassacarìdeo ou polissacarìdeo capsular
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
EP2155244B1
(de)
|
2007-04-23 |
2017-03-22 |
Serum Institute of India Private Limited |
Antigene polysaccharide und verfahren zu ihrer herstellung
|
SI2167121T1
(sl)
|
2007-06-26 |
2015-12-31 |
Glaxosmithkline Biologicals S.A. |
Cepivo, ki obsega kapsularne polisaharidne konjugate Streptococcusa pneumoniae
|
EP2217250A4
(de)
|
2007-11-09 |
2011-01-05 |
California Inst Of Techn |
Immunmodulierende verbindungen und relevante zusammensetzungen und verfahren
|
JP2012504660A
(ja)
|
2008-10-06 |
2012-02-23 |
ユニバーシティ オブ シカゴ |
細菌eap、empおよび/またはadsaタンパク質に関連する組成物および方法
|
CN102257155B
(zh)
*
|
2008-12-18 |
2016-03-02 |
惠氏有限责任公司 |
控制肺炎链球菌血清型19a多糖分子量的方法
|
ES2749952T3
(es)
*
|
2008-12-18 |
2020-03-24 |
Wyeth Llc |
Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
|
US9567379B2
(en)
|
2009-04-03 |
2017-02-14 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) variants
|
US20120135037A1
(en)
|
2009-06-01 |
2012-05-31 |
Mizel Steven B |
Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
TW201136603A
(en)
*
|
2010-02-09 |
2011-11-01 |
Merck Sharp & Amp Dohme Corp |
15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
|
ES2694100T3
(es)
|
2010-04-07 |
2018-12-18 |
California Institute Of Technology |
Vehículo para distribuir un compuesto en una membrana mucosa y composiciones, procedimientos y sistemas relacionados
|
US20110287048A1
(en)
|
2010-05-20 |
2011-11-24 |
Round June L |
Antigen Specific Tregs and related compositions, methods and systems
|
WO2011148382A1
(en)
|
2010-05-28 |
2011-12-01 |
Biological E Limited |
An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol.
|
SG186290A1
(en)
|
2010-07-02 |
2013-01-30 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
JP5793194B2
(ja)
|
2010-09-09 |
2015-10-14 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
感染防御ブドウ球菌抗原が関与する方法および組成物
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
BR112013024322B1
(pt)
|
2011-03-22 |
2020-04-22 |
Serum Inst India Ltd |
processo para preparação de polissacarídeos
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
EP2731617A4
(de)
|
2011-07-12 |
2015-07-01 |
Brigham & Womens Hospital |
Lipidhaltige psa-zusammensetzungen, verfahren zu ihrer isolierung und verwendungsverfahren dafür
|
SI3106176T1
(en)
|
2011-12-06 |
2018-04-30 |
Valneva Austria Gmbh |
Aluminum compounds for use in therapeutics and vaccines
|
JP6670106B2
(ja)
|
2012-04-26 |
2020-03-18 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
ブドウ球菌コアグラーゼ抗原およびその使用方法
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
JP5905649B2
(ja)
*
|
2012-09-07 |
2016-04-20 |
エスケー ケミカルズ カンパニー, リミテッドSk Chemicals Co., Ltd. |
肺炎球菌血清型を有する莢膜多糖類の製造方法
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
WO2014182966A1
(en)
|
2013-05-10 |
2014-11-13 |
California Institute Of Technology |
Probiotic prevention and treatment of colon cancer
|
WO2015095868A1
(en)
|
2013-12-20 |
2015-06-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
HRP20231504T1
(hr)
*
|
2014-01-21 |
2024-03-01 |
Pfizer Inc. |
Polisaharidi kapsule iz bakterije streptococcus pneumoniae i njihovi konjugati
|
US9107906B1
(en)
|
2014-10-28 |
2015-08-18 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
EP3288983A1
(de)
|
2015-04-28 |
2018-03-07 |
Biological E Limited |
Verfahren zur abscheidung von protein- und anderen verunreinigungen aus mikrobiellen kapsulären polysacchariden
|
WO2016201342A1
(en)
|
2015-06-10 |
2016-12-15 |
California Institute Of Technology |
Sepsis treatment and related compositions methods and systems
|
US10857177B2
(en)
|
2015-08-19 |
2020-12-08 |
President And Fellows Of Harvard College |
Lipidated PSA compositions and methods
|
US10946085B2
(en)
*
|
2016-02-15 |
2021-03-16 |
Hipra Scientific, S.L.U. |
Streptococcus uberis extract as an immunogenic agent
|
WO2017153316A1
(en)
|
2016-03-07 |
2017-09-14 |
Glaxosmithkline Biologicals Sa |
Drug delivery particles
|
US11058757B2
(en)
|
2016-03-31 |
2021-07-13 |
Pogona, LLC |
Saccharide-polypeptide conjugate compositions and methods of use thereof
|
WO2017220753A1
(en)
|
2016-06-22 |
2017-12-28 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
EP3269385A1
(de)
|
2016-07-12 |
2018-01-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumokokken-polysaccharid-proteinkonjugatzusammensetzung
|
US11491181B2
(en)
|
2016-07-15 |
2022-11-08 |
President And Fellows Of Harvard College |
Glycolipid compositions and methods of use
|
EA039427B1
(ru)
|
2016-08-05 |
2022-01-26 |
Санофи Пастер Инк. |
Поливалентная пневмококковая полисахаридно-белковая конъюгатная композиция
|
KR102437120B1
(ko)
|
2016-08-05 |
2022-08-25 |
사노피 파스퇴르 인코포레이티드 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR102650073B1
(ko)
|
2017-01-31 |
2024-03-20 |
머크 샤프 앤드 돔 엘엘씨 |
스트렙토코커스 뉴모니아 혈청형 19f 유래의 협막 다당류 단백질 접합체의 제조 방법
|
US11400162B2
(en)
|
2017-02-24 |
2022-08-02 |
Merck Sharp & Dohme Llc |
Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
AU2018280272C1
(en)
|
2017-06-10 |
2021-05-06 |
Inventprise, Inc. |
Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
CA3068983A1
(en)
|
2017-07-05 |
2019-01-10 |
Inventprise, Llc |
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
|
US10702596B2
(en)
|
2017-07-05 |
2020-07-07 |
Inventprise, Llc |
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
|
AU2018328040A1
(en)
*
|
2017-09-07 |
2020-03-19 |
Merck Sharp & Dohme Llc |
Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
|
BR112020004471A8
(pt)
|
2017-09-07 |
2022-11-01 |
Merck Sharp & Dohme |
Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora
|
US11491216B2
(en)
*
|
2017-09-07 |
2022-11-08 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
US11524076B2
(en)
|
2017-09-07 |
2022-12-13 |
Merck Sharp & Dohme Llc |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
CA3074708A1
(en)
|
2017-09-07 |
2019-03-14 |
Merck Sharp & Dohme Corp. |
Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
|
JP7218358B2
(ja)
|
2017-09-07 |
2023-02-06 |
メルク・シャープ・アンド・ドーム・エルエルシー |
肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用
|
CA3084436A1
(en)
|
2017-12-06 |
2019-07-18 |
Merck Sharp & Dohme Corp. |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
KR20210093854A
(ko)
*
|
2018-09-12 |
2021-07-28 |
아피니백스, 인크. |
다가 폐렴구균 백신
|
EP3897705A2
(de)
|
2018-12-19 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Zusammensetzungen mit polysaccharidproteinkonjugaten von streptococcus pneumoniae und verfahren zu deren verwendung
|
MX2021013736A
(es)
|
2019-05-10 |
2021-12-10 |
Glaxosmithkline Biologicals Sa |
Produccion de conjugados.
|
MX2022001241A
(es)
|
2019-07-31 |
2022-04-20 |
Sanofi Pasteur Inc |
Composiciones de conjugados neumococicos multivalentes polisacarido - proteina y metodos para usar los mismos.
|
US20210070890A1
(en)
|
2019-09-06 |
2021-03-11 |
Serum Institute Of India Private Limited |
Method for obtaining purified bacterial polysaccharides
|
CN114728051A
(zh)
|
2019-11-22 |
2022-07-08 |
葛兰素史克生物有限公司 |
细菌糖糖缀合物疫苗的剂量和施用
|
EP3900739A1
(de)
|
2020-04-21 |
2021-10-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetische streptococcus-pneumoniae-saccharid-konjugate zum konservierten membranprotein
|
EP3919076A1
(de)
|
2020-06-02 |
2021-12-08 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Synthetische oligosaccharidimpfstoffe gegen streptococcus pneumoniae mit mikropartikel-adjuvans-formulierungen
|
US20230250142A1
(en)
|
2020-06-12 |
2023-08-10 |
Glaxosmithkline Biologicals Sa |
Dock tag system
|
TW202245835A
(zh)
|
2021-02-04 |
2022-12-01 |
美商默沙東有限責任公司 |
用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
|
WO2022180648A1
(en)
*
|
2021-02-26 |
2022-09-01 |
Biological E Limited |
Activated-quenched polysaccharide and improved methods for quantification of polysaccharide in a vaccine composition
|
EP4169513A1
(de)
|
2021-10-19 |
2023-04-26 |
GlaxoSmithKline Biologicals S.A. |
Hilfsstoffzusammensetzung enthaltend sting agonisten
|
WO2024062494A1
(en)
|
2022-09-19 |
2024-03-28 |
Biological E Limited |
Method for the purification of capsular polysaccharides
|